Myocardial viability studies using fluorine-18-FDG SPECT: A comparison with fluorine-18-FDG PET

Journal of Nuclear Medicine

Volumn 38, Issue 4, 1997, Pages 582-586

  Chen, Eric Q ^a   Maclntyre, William J ^a   Go, Raymundo T ^a   Brunken, Richard C ^a   Saha, Gopal B ^a   Ching yee, O Wong ^a   Neumann, Donald R ^a   Cook, Sebastian A ^a   Khandekar, Shashi P ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

fluorine 18 FDG; myocardial viability; SPECT

Indexed keywords

DIPYRIDAMOLE; FLUORINE 18;

ARTICLE; CLINICAL ARTICLE; COST BENEFIT ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; FEMALE; HEART DISEASE; HEART FUNCTION; HUMAN; MALE; MEDICAL DECISION MAKING; PATIENT SELECTION; PHOTON; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; QUANTITATIVE DIAGNOSIS; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

CORONARY CIRCULATION; DEOXYGLUCOSE; FLUORINE RADIOISOTOPES; FLUORODEOXYGLUCOSE F18; HEART; HUMANS; RUBIDIUM RADIOISOTOPES; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, EMISSION-COMPUTED; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0030891957     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Tillisch J, Brunken RC, Schwaiger M, Mandelkern M, Phelps ME, Scheiben FR. Reversibility of cardiac wall molion abnormality predicted by positron tomography. New Eng J Med 1986:314:884-888.
2. Stoll H-P, Hellwig NH. Alexander C, Ozbek C, Schieffer H, Oberhausen E. Myocardial metabolic imaging by means of fluorine-18-deoxyglucose/technetiu n99m-sestamibi dual isotope single-photon emission tomography. Eur J Nucl Med 1994:21:1085-11093.
3. Martin WH, Delbeke D, Patton JA, et al. FDG-SPECT: Correlation with FDG-PET. JNucI Med 1995:36:988-995.
4. Dräne WE, Abott FD, Nicole MW, Mastin ST, Kuperus JH. Technology lör FDG-SPECT with a relatively inexpensive gamma camera: work-in-progress. Radiolos,- 1994:191:461-465.
5. Bun RW, Perkins OW, Oppenheim BE, et al. Direct comparison of fluorine-18-FC G SPECT, fluorine-18-FDG PET and rest thallium-201 SPECT for detection of myoc: rdial viability. J Nucl Med 1995:36:176-179.
6. Go RT, Marwick TH. Maclntyre WJ. et al. A prospective comparison of rubidium-!!2 PET and thallium-201 SPECT myocardial perfusion imaging utilizing a single dipyridamole stress in the diagnosis of coronary artery disease. J Nucl Med 1990:31 : 1899-1905.
7. Performance measurements of scintillation cameras. Publication No. 1-1980. Was iington. DC: National Electrical Manufacturers Association.
8. Go RT. Maclntyre WJ, Sana GB. et al. Hibernating myocardium versus scar: severi y of irreversibly decreased myocardial perfusion in prediction of tissue viability. Radiology 1995;194:151-155.
9. McCord ME, Bacharach SL, Bonow RO. Dilsizian V, Cuocolo A. Freedman N. Misalignment between PET transmission and emission scans: its effect on myocardial imaging. J Nucl Med 1992:33:1209-1214.
10. Sorenson JA, Phelps ME. Phvstcs in nuclear medicine. New York: Grune & Strattou: 1980:264.
11. Fleiss JL. Statistical methods for rates and proportions, 2nd ed. New York: John Wiley and Sons: 1983:212.
12. Go RT, Maclntyre WJ, Cook SA, et al. The incidence of scintigraphically viable and nonviable tissue by rubidium-82 and fluorine-18-fluorodeoxyglucose-labeled positron emission tomographic imaging in patients with prior infarction and left ventriculsr dysfunction. J Nucl Cardiol 1996:3:96-104.